1 year return (CAGR)
46.98%
Cerevel Therapeutics Holdings Inc Exchange (NASDAQ, USD)
CERE
-
+0.33 (+0.74%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
21.71%
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
8.19B
Price/Sales
993.39
Ent value
8.43B
Price/Book
14.51
Div yield
-
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 44.99 |
| Daily high | 44.99 |
| Daily low | 44.96 |
| Daily Volume | 15.1M |
| 1y analyst estimate | 43.40 |
| Beta | 1.41 |
| EPS (TTM) | -2.54 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| CERE | S&P500 | |
| Current price drop from All-time high | -0.02% | -2.49% |
| Highest price drop | -54.61% | -56.47% |
| Date of highest drop | 22 Sep 2023 | 9 Mar 2009 |
| Avg drop from high | -23.95% | -10.68% |
| Avg time to new high | 27 days | 12 days |
| Max time to new high | 686 days | 1805 days |
News
No items found